FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.3  |  FHIR Version n/a  User: [n/a]

38112003: 1 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2023. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    64719019 One en Synonym Active Entire term case insensitive SNOMED CT core module
    771016011 One (qualifier value) en Fully specified name Inactive Only initial character case insensitive SNOMED CT core module
    3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive SNOMED CT core module
    3442105014 1 en Synonym Active Entire term case insensitive SNOMED CT core module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    1 Is a General adjectival modifier false Inferred relationship Existential restriction modifier
    1 Is a Number false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Product containing precisely atazanavir (as atazanavir sulfate) 200 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely rasagiline 1 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely cimetidine 200 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely tetracaine 40 milligram/1 gram conventional release cutaneous gel Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely acetylcysteine 200 milligram/1 milliliter conventional release eye drops Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely silodosin 4 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely risperidone 1 milligram/1 milliliter conventional release oral solution Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely mesuximide 150 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely erythromycin 40 milligram/1 gram conventional release cutaneous gel Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely cyproheptadine hydrochloride 4 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely amprenavir 150 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely ramipril 1.25 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely atazanavir (as atazanavir sulfate) 300 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely ampicillin 500 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely stavudine 40 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely flucloxacillin (as flucloxacillin sodium) 500 milligram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely lornoxicam 4 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely oxprenolol hydrochloride 20 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely propiverine hydrochloride 15 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely thiopental sodium 500 milligram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely galantamine (as galantamine hydrobromide) 12 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely calcium phosphate 3.3 gram/1 sachet powder for conventional release oral suspension Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely ethionamide 250 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely mebeverine hydrochloride 100 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely ferrous sulfate 200 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely hydroxyzine hydrochloride 25 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely thiotepa 15 milligram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely monobasic potassium phosphate 500 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely testosterone undecanoate 40 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely paromomycin (as paromomycin sulfate) 250 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely tadalafil 20 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely flurbiprofen 8.75 milligram/1 each conventional release oromucosal lozenge Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely cefixime 200 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely trihexyphenidyl hydrochloride 5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely cinchocaine hydrochloride 11 milligram/1 gram conventional release cutaneous ointment Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely bezafibrate 200 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely diazepam 1 milligram/1 milliliter conventional release oral solution Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely demeclocycline hydrochloride 150 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely cerivastatin sodium 100 microgram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely amobarbital sodium 500 milligram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely eltrombopag 25 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely apixaban 2.5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely debrisoquine 10 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely nefazodone hydrochloride 100 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely mepyramine maleate 20 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely retigabine 50 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely isoniazid 300 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely fluorouracil 5 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely procyclidine hydrochloride 5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely haloperidol 1.5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely zinc sulfate 220 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely verapamil hydrochloride 120 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely nabumetone 500 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 25 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely clotrimazole 10 milligram/1 milliliter conventional release cutaneous spray Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely benzocaine 30 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely lacosamide 100 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely metoclopramide hydrochloride 5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely spironolactone 100 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Hydrocortisone acetate powder Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely ketoprofen 25 milligram/1 gram conventional release cutaneous gel Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely prochlorperazine maleate 25 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely risedronate sodium 35 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely calcitriol 3 microgram/1 gram conventional release cutaneous ointment Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely zonisamide 25 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely bimatoprost 300 microgram/1 milliliter conventional release eye drops Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely calcium carbonate 1.25 gram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely neomycin sulfate 25 milligram/1 milliliter conventional release oral solution Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely nonoxinol 20 milligram/1 milliliter conventional release vaginal gel Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely nystatin 100000 unit/1 gram conventional release cutaneous cream Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely hydrocortisone 10 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely phenoxybenzamine hydrochloride 10 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely ergometrine maleate 500 microgram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely dofetilide 250 microgram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely ganciclovir 500 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely memantine hydrochloride 10 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely metoprolol tartrate 100 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely prochlorperazine mesilate 5 milligram/1 sachet conventional release effervescent oral granules (clinical drug) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely cinacalcet (as cinacalcet hydrochloride) 30 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely mesalazine 400 milligram/1 each gastro-resistant oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely glimepiride 2 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely imidapril hydrochloride 20 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely propranolol hydrochloride 160 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely alfacalcidol 2 microgram/1 milliliter conventional release oral drops Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely rifaximin 200 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely benzalkonium chloride 10 milligram/1 milliliter conventional release cutaneous solution Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely metronidazole (as metronidazole benzoate) 40 milligram/1 milliliter conventional release oral suspension Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely valproic acid (as valproate semisodium) 500 milligram/1 each gastro-resistant oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely trandolapril 500 microgram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely bromocriptine (as bromocriptine mesilate) 10 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely tizanidine (as tizanidine hydrochloride) 2 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely idarubicin hydrochloride 5 milligram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely oxazepam 10 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely lamotrigine 200 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely cyproterone acetate 50 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely fludarabine phosphate 10 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely ephedrine hydrochloride 15 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely diazepam 5 milligram/1 milliliter conventional release oral solution Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely phenytoin sodium 50 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely glibenclamide 5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely primaquine (as primaquine phosphate) 26.3 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier

    Start Previous Page 262 of 342 Next End

    This concept is not in any reference sets

    Back to Start